2019, Number 4
<< Back
Rev Hematol Mex 2019; 20 (4)
Some data of T/NK lymphoma
Trigos-Pérez ÁF, Marín-Corte JCA, Arroyo-Altamirano AG, Ruiz-Argüelles GJ
Language: Spanish
References: 14
Page: 287-292
PDF size: 271.22 Kb.
ABSTRACT
Natural killer/T cell lymphomas (NKTCL) are rare neoplasms of which there are a
limited bibliographical information and minimum experience in their treatment, they
are rapidly evolving and with poor prognosis. It is known that some risk factors for
developing this neoplasm are exposure to pesticides, solvents, infection by Epstein-Barr
virus (EBV) and Asian and Hispanic American ancestry. Some of the most important
prognostic factors are the clinical stages of Ann-Arbor at the time of diagnosis, which
is related to achieving an opportune diagnosis since most of these patients are late in
diagnosis. Other important factors in the prognosis are the extension to the central
nervous system (CNS), adulthood and certain biochemical markers, such as lactic
dehydrogenase (DHL) and fibrinogen.
REFERENCES
Wajda BN, Rabinowitz MR, Nyquist GG, et al. Paranasal sinus lymphoma: retrospective review with focus on clinical features, histopathology, prognosis, and relationship to systemic lymphoma. Head Neck 2017;39(6):1065-1070. doi: 10.1002/hed.24686.
Haverkos BM, Pan Z, Gru AA, et al. Extranodal NK/T cell lymphoma, nasal type (ENKTL-NT): An update on epidemiology, clinical presentation, and natural history in North American and European cases. Curr Hematol Malig Rep 2016;11(6):514-527. doi:10.1007/s11899-016-0355-9.
Elshiekh M, Naresh KN. A rare case of renal intravascular NK/T-cell lymphoma. Blood 2008;132(12):1354. doi:10.1182/blood-2018-06-856724.
Ito H, Hiraiwa S, Sugiyama T, et al. An autopsy case of primary extranodal NK/T cell lymphoma (extranodal NK/T cell lymphoma) of the bile duct. J Clin Gastroenterol 2019. doi:10.1007/s12328-018-00931-1.
Valdivia-Ferrufino D, Assis MA, Pérez-Romano B, et al. Neoplasias de células NK: informe de catorce casos estudiados en una sola institución. Hematología 2010;11(3):129-135.
Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016;127(20):2375-2390. doi 10.1182/ blood-2016- 01-643569.
Chihara D, Oki Y. NK-Cell Lymphomas. 163-184 C. Querfeld et al. (eds.), T-Cell and NK-Cell Lymphomas, Cancer Treatment and Research 2019; 176. Springer, Cham. https://doi.org/10.1007/978-3-319-99716-2_8.
Varelas AN, Ganti A, Eggerstedt M, et al. Prognostic indicators of survival in sinonasal extranodal natural killer/T-cell lymphoma. Laryngoscope 2019; 00:1-6. doi: 10.1002/ lary.27886.
Yamaguchi M, Suzuki R, Oguchi M. Advances in the treatment of extranodal NK/T-cell lymphoma, nasal type. Blood 2018;131(23):2528-2540. doi:10.1182/ blood-2017-12-791418.
Nevel K, Daras M. Clinical presentation, treatment, and outcome in patients with central nervous system involvement of extranodal natural killer/t-cell lymphoma. Neuro-Oncology 2017;19(6):vi42. doi:10.1093/neuonc/nox168.163.
Hu Z, Wang Y. The factors associated with the early diagnosis of nasal NK/T-cell lymphoma with prominent ocular symptoms and general nasal NKTL. Am J Otolaryngol https://doi.org/10.1016/j.amjoto.2019.01.012.
Sánchez‑Romero C, Paes de Almeida O, Rendón-Henao J, et al. Extranodal NK/T-cell lymphoma, nasal type in Guatemala: An 86-case series emphasizing clinical presentation and microscopic characteristics. Head Neck Pathol 2019; first on line. https://doi.org/10.1007/s12105-019-01027-z
Liu YZ, Bi LQ, Chang GL, et al. Clinical characteristics of extranodal NK/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis. Cancer Manag Res 2019;11:997-1002. doi:10.2147/CMAR.S18378
Wong DJY, Parry LA, Bloch AE, et al. Extranodal NK/T cell lymphoma, nasal type, with retrobulbar extraconal phlegmon and naso-oral fistula. BMJ Case Rep 2019;12:e227160. doi:10.1136/bcr-2018-227160.
Full text